1.
The Study of Induction on Silenced Fragile X Mental Retardation-1 Gene Expression by Adenylate Cyclase Activator;
腺苷酸环化酶激活剂诱导脆性X智力低下一号封闭基因重新表达的初步研究
2.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
3.
3D-QSAR study for novel inhibitors of mitogen activated protein kinase-activated protein kinase 2
促分裂原活化蛋白激酶激活的蛋白激酶-2全新抑制剂的3D-QSAR研究
4.
Recent Advance on p38 Mitogen-Activated Protein Kinases Inhibitors
p38丝裂原活化蛋白激酶抑制剂研究进展
5.
We prepared pancreatin having high activity by using activator and stabilizer of enzyme.
将酶激活剂及稳定剂用于高活力胰酶生产.
6.
Pituitary adenylate cyclase-activating polypeptide modulates immune function of LPS-stimulatd dendritic cells
垂体腺苷酸环化酶激活多肽调节LPS激活的树突状细胞免疫功能
7.
Studies on Stability and Inactivation/Activation Mechanism of Chloroperoxidase Based on Additives;
基于添加剂的氯过氧化物酶稳定化及失活和激活机理研究
8.
Virtually Screening for Natural Pan Agonists of the Peroxisome Proliferator Actived Receptors
过氧化物酶体增殖物激活受体天然泛激动剂的虚拟筛选
9.
Purification, Characterization and Anti-thrombus Effect of a Plasminogen Activator from Gloydius Brevicaudus Venom;
短尾蝮蛇毒纤溶酶原激活剂的分离纯化及活性测定
10.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
11.
Coexpression of Growth Hormone Releasing Factor and Pituitary Adenylate Cyclase Activating Polypeptide Genes;
生长激素释放因子和垂体腺苷酸环化酶激活肽基因的共表达
12.
Dynamic changes and its significance of urokinase-plasminogen activator during forming progress of cholestatic liver fibrosis in rats
尿激酶型纤溶酶原激活剂在大鼠胆汁淤积性肝纤维化形成过程中的动态变化及其意义
13.
A Study of the Level of Cyclooxygenase-2 and Urokinase-type Plasminogen Activator in the Left and Right Atrium of Acute Atrial Fibrillation in Canines;
犬急性心房颤动时心房环氧酶-2与尿激酶型纤溶酶原激活物的变化
14.
Treatment of Experimental Hepatic Fibrosis by Combination of Urokinase-type Plasminogen Activator and Hepatocyte Growth Factor Gene Delivery;
尿激酶型纤溶酶原激活剂和肝细胞生长因子联合基因治疗实验性肝纤维化
15.
Effect of Chinese Hebal Compound of Different Treating Principles on uPA of Cholestasis-induced Liver Fibrosis Rat
不同治则中药复方对胆汁淤积性肝纤维化大鼠尿激酶型纤溶酶原激活剂的影响
16.
Intrathecal Injection NMDA Receptor Agonist NMDA Up-regulates COX-2 Expression in the Spinal Dorsal Horn in Rats;
鞘内注射NMDA受体激动剂NMDA上调大鼠脊髓后角环氧化酶-2的表达
17.
The Role of the Plasminogen Activator Inhibitor-1 in the Pathogenesis of Hepatic Fibrosis;
纤溶酶原激活物抑制剂-1在肝纤维化发生中的作用
18.
Prokaryotic Expression, Purification, and Identification of Plasminogen Activator from Gloydius Brevicaudus;
江浙短尾蝮蛇纤溶酶原激活剂的原核表达、纯化及其鉴定